(Study: Wadden et al., 2021) Efficacy: Clinical trials have demonstrated remarkable weight loss results, making Wegovy a promising option for individuals struggling with obesity
The EXSCEL trial, which followed exenatide (another GLP-1 agonist) users for approximately three years across roughly 83,000 patient-years of follow-up, found no evidence that treatment increases serum calcitonin concentrations or risk of MTC in humans
Upon ligand binding, GLP-1R activation enhances glucose-dependent insulin secretion, suppresses glucagon release, delays gastric emptying, and reduces appetite, collectively improving glycemic control and promoting clinically meaningful weight reduction [19]
Will my PCOS symptoms return if I stop the medication
People couldn't access the brand-name weight-loss drugs like Ozempic and Mounjaro because high demand triggered shortages
This means the FDA does not review these drugs to evaluate their safety, effectiveness, or quality before they are marketed." (Source: FDA "Compounding and the FDA: Questions and Answers".) Clinical efficacy data such as the 14.9% mean weight loss from the STEP 1 trial or the 22.5% from SURMOUNT-1 comes from studies of the FDA-approved formulations, not from compounded versions